ArticleCancer research2024

CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer.

Jesse Boumelha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.